Roughly 200 million people worldwide live with age-related macular degeneration, a condition that erodes central vision and, ...

PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery technology, will be presenting the results ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Science Corporation ...

(BPT) - Age-related macular degeneration (AMD) once meant a slow, irreversible loss of vision, and many people still believe that's true. But the AMD of today isn't the AMD of a generation ago.

AUSTIN (KXAN) — Debbie Pearson has spent more than half her life caring for others as a nurse. Last fall, an annual eye exam at Austin Retina Associates led to doctors discovering wet age-related ...

The MarketWatch News Department was not involved in the creation of this content. IDE approval by the FDA expands global trial to the United States as first study participant is treated in the United ...

But catching AMD early and working closely with a retina specialist gives patients the best chance to preserve their sight and their quality of life." Nearly 20 million Americans are living with AMD, ...